DJIA 17,719.92 -78.57 -0.44%
NASDAQ 5,108.67 -18.86 -0.37%
S&P 500 2,080.41 -9.70 -0.46%
market minute promo

Pfizer (NYSE: PFE)

32.77 -0.02 (-0.06%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

PFE $32.77 -0.06%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $32.91
Previous Close $32.79
Daily Range $32.53 - $32.91
52-Week Range $28.47 - $36.46
Market Cap $202.3B
P/E Ratio 24.65
Dividend (Yield) $1.12 (3.4%)
Ex-Dividend Date
Dividend Pay Date
Volume 42,887,875
Average Daily Volume 39,631,697
Current FY EPS $2.18




Drug Makers

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website:

News & Commentary Rss Feed

3 Companies That Could Become Tax Inversion Targets

The Pfizer-Allergan deal may not be the last tax inversion deal we witness. These three companies could also become the target of a U.S.-based buyer.

5 Top Income Stocks Boosting Their Already Big Payout

Dow Jones Industrial Average Falls 78 Points on Cyber Monday

Sosei Subsidiary Heptares Announces Strategic Drug Discovery Collaboration with Pfizer

Insurers Don't Want to Pay for Pricey Cancer Meds

High-priced cancer drugs are increasingly being placed in the highest tiers of insurers' drug formularies.

Pfizer-Allergan Merger: More Than A U.S. Tax Dodge? (Video)

What Healthcare Dividend Stock Is Best?

One Motley Fool contributor evaluates three healthcare dividend companies to determine which may be the best investment.

The Most Important Message From Charlie Sheen's Recent HIV Admission

Charlie Sheen stunned the world with his HIV admission, but there's a far bigger lesson behind this announcement.

Merck KGaA-Pfizer's Avelumab May Get Orphan Status in EU

Stock Market News for November 27, 2015

See More PFE News...

PFE's Top Competitors

PFE $32.77 (-0.06%)
Current stock: PFE
JNJ $101.24 (-1.10%)
Current stock: JNJ
ROG $55.43 (0.31%)
Current stock: ROG
GSK $40.51 (-1.10%)
Current stock: GSK